| Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled … S Askari, S Mokhtari, SV Shariat, B Shariati, M Yarahmadi, M Shalbafan BMC psychiatry 22 (1), 34, 2022 | 19 | 2022 |
| The impact of the COVID-19 pandemic on Iranian psychiatric trainees’ and early career psychiatrists’ well-being, work conditions, and education N Eissazade, M Shalbafan, F Saeed, D Hemmati, S Askari, ... Academic Psychiatry 46 (6), 710-717, 2022 | 4 | 2022 |
| The effect of drug holidays on sexual dysfunction in men treated with selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine: an 8-week open-label randomized … A Alipour-Kivi, N Eissazade, SV Shariat, R Salehian, S Soraya, S Askari, ... BMC psychiatry 24 (1), 67, 2024 | 3 | 2024 |
| Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial M Shokrani, S Askari, N Eissazade, SV Shariat, B Shariati, M Yarahmadi, ... BMC psychiatry 23 (1), 686, 2023 | 2 | 2023 |
| Safety and Efficacy of Drug holidays for women with sexual Dysfunction Induced by selective serotonin reuptake inhibitors (SSRIs) other than fluoxetine: an open-label … E Lalegani, N Eissazade, M Shalbafan, R Salehian, SV Shariat, S Askari, ... Brain Sciences 13 (10), 1397, 2023 | 1 | 2023 |
| Integrating artificial intelligence and telehealth services in psychodermatology. N Hashmi, M Noorani, A Ventriglio, D De Berardis, I Ullah, S Askari, ... Journal of Cosmetic Dermatology 22 (2), 2023 | 1 | 2023 |
